In amyotrophic lateral sclerosis (ALS), genetic abnormalities damage motor neurons, resulting in rapidly-progressing neurodegeneration, muscle wasting, and irreversible disability. Current imaging strategies (T2w, DTI, fMRI) monitor structural changes to motor neurons. Here, we investigated continuous wave chemical exchange saturation transfer (CEST) MRI to monitor molecular changes resulting from these abnormalities as a potentially complementary imaging biomarker for monitoring ALS disease progression.
This abstract and the presentation materials are available to members only; a login is required.